PEAK6 Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-37,204
Closed -$1.17M 4900
2015
Q4
$1.11M Buy
37,204
+33,589
+929% +$1.13M 0.01% 1834
2015
Q3
$114K Buy
+3,615
New +$176K ﹤0.01% 4217
2015
Q2
Sell
-699
Closed -$29.5K 5365
2015
Q1
$30K Buy
+699
New +$25.1K ﹤0.01% 4407
2013
Q4
Sell
-163,019
Closed -$3.29M 5315
2013
Q3
$1.85M Buy
+163,019
New +$3.76M 0.01% 1605

Other funds holding PGEN

PEAK6 Group's PGEN Position: Q1 2016 in Review

PEAK6 Group sold out of Precigen (PGEN) in Q1 2016, closing a stake of 37,204 shares — an estimated $1.17M sold.

PEAK6 Group first reported a position in PGEN in Q3 2013 and held it in 4 quarters. The position peaked at $1.85M in Q3 2013. 191 funds tracked by Wall St. Rank hold PGEN as of Q1 2016.

  • PEAK6 Group reported no remaining Precigen position as of Q1 2016 after selling out during the quarter.
  • PEAK6 Group sold 37,204 Precigen shares in Q1 2016, an estimated $1.17M.
  • PEAK6 Group first reported a position in Precigen in Q3 2013 and held it in 4 quarters.
  • PEAK6 Group's Precigen position peaked at $1.85M in Q3 2013.
  • 191 funds tracked by Wall St. Rank held Precigen as of Q1 2016.

Based on PEAK6 Group's 13F filing for Q1 2016, filed 13 May 2016.